BACKGROUND The relationship between diabetes mellitus(DM)and asthma is complex and can impact disease trajectories.AIM To explore the bidirectional influences between the two conditions on clinical outcomes and diseas...BACKGROUND The relationship between diabetes mellitus(DM)and asthma is complex and can impact disease trajectories.AIM To explore the bidirectional influences between the two conditions on clinical outcomes and disease control.METHODS We systematically reviewed the literature on the relationship between DM and asthma,focusing on their impacts,mechanisms,and therapeutic implications.Various studies were assessed,which investigated the effect of glycemic control on asthma outcomes,lung function,and exacerbations.The study highlighted the role of specific diabetes medications in managing asthma.RESULTS The results showed that poor glycemic control in diabetes can exacerbate asthma,increase hospitalizations,and reduce lung function.Conversely,severe asthma,especially in obese individuals,can complicate diabetes management and make glycemic control more difficult.The diabetes-associated mechanisms,such as inflammation,microangiopathy,and oxidative stress,can exacerbate asthma and decrease lung function.Some diabetes medications exhibit anti-inflammatory effects that show promise in mitigating asthma exacerbations.CONCLUSION The complex interrelationship between diabetes and asthma suggests bidirectional influences that affect disease course and outcomes.Inflammation and microvascular complications associated with diabetes may worsen asthma outcomes,while asthma severity,especially in obese individuals,complicates diabetes control.However,the current research has limitations,and more diverse longitudinal studies are required to establish causal relationships and identify effective treatment strategies for individuals with both conditions.展开更多
Bronchial asthma is divided into type 2 and non-type 2 asthma based on the immunopathogenesis.Type 2 inflammation is an inflammation mediated by T helper 2 cells,group 2 innate lymphoid cells and sustained by a specif...Bronchial asthma is divided into type 2 and non-type 2 asthma based on the immunopathogenesis.Type 2 inflammation is an inflammation mediated by T helper 2 cells,group 2 innate lymphoid cells and sustained by a specific subset of cytokines.In recent years,type 2 asthma has become the research hotspot in the field of asthma.For type 2 asthma,targeted therapies have become effective treatments and widely used in clinical practice.In order to further understand the progress of biologic drugs for bronchial asthma,as well as the disease outcomes in patients with type 2 asthma,and improve asthma control and remission,this article reviewed the progress and achievements of biologic drugs for asthma from May 1,2023 to April 30,2024,providing clinical perspective for the choosing appropriate targeted treatment of asthma.It also highlights selected poster pre-sentations from the ATS 2024 Annual Meeting to provide clinical insights for choosing appropriate targeted treatments for Type 2 asthma.展开更多
The global incidence of asthma,a leading respiratory disorder affecting more than 235 million people,has dramatically increased in recent years.Characterized by chronic airway inflammation and an imbalanced response t...The global incidence of asthma,a leading respiratory disorder affecting more than 235 million people,has dramatically increased in recent years.Characterized by chronic airway inflammation and an imbalanced response to airborne irritants,this chronic condition is associated with elevated levels of inflammatory factors and symptoms such as dyspnea,cough,wheezing,and chest tightness.Conventional asthma therapies,such as corticosteroids,long-actingβ-agonists,and antiinflammatory agents,often evoke diverse adverse reactions and fail to reduce symptoms and hospitalization rates over the long term effectively.These limitations have prompted researchers to explore innovative therapeutic strategies,including stem cell-related interventions,offering hope to those afflicted with this incurable disease.In this review,we describe the characteristics of stem cells and critically assess the potential and challenges of stem cell-based therapies to improve disease management and treatment outcomes for asthma and other diseases.展开更多
BACKGROUND Diffuse panbronchiolitis(DPB)is a rare,chronic inflammatory lung disease mar-ked by chronic cough,breathlessness,and preceding sinusitis.Symptoms often persist for years and can be misdiagnosed as asthma,pa...BACKGROUND Diffuse panbronchiolitis(DPB)is a rare,chronic inflammatory lung disease mar-ked by chronic cough,breathlessness,and preceding sinusitis.Symptoms often persist for years and can be misdiagnosed as asthma,particularly in children.This report describes a DPB case resolved with long-term azithromycin therapy,em-phasizing the need for a timely and accurate diagnosis.CASE SUMMARY A 12-year-old girl,diagnosed with asthma at age five and managed with inhaled corticosteroids and long-acting beta-2 agonists,developed a history of chronic productive cough and chronic sinusitis for a year.On examination,she exhibited wheezing and coarse crackles.Despite receiving treatment for an asthma exacer-bation,her symptoms did not improve.A chest X-ray revealed reticulonodular infiltration in both lower lungs,prompting further evaluation with high-resolu-tion computed tomography(HRCT).The HRCT confirmed centrilobular nodule opacities,a'tree-in-bud'pattern,and non-tapering bronchi,suggesting DPB.Elevated cold hemagglutinin titers at 128 further supported the diagnosis.Her cough and sinusitis resolved within a month after starting azithromycin therapy,chosen for its anti-inflammatory and immunomodulatory effects.Follow-up HRCT scans after 1 year of continuous treatment showed complete normalization.CONCLUSION This case highlights the importance of early diagnosis and prompt treatment in achieving favorable outcomes for DPB.展开更多
Background:To appraise the ameliorative potentials of Allium sativum aqueous extract in ovalbumin(OVA)-lipopolysaccharide(LPS)-induced asthma.Methods:Extraction,phytochemical analysis,determination of bioactive compou...Background:To appraise the ameliorative potentials of Allium sativum aqueous extract in ovalbumin(OVA)-lipopolysaccharide(LPS)-induced asthma.Methods:Extraction,phytochemical analysis,determination of bioactive compounds and LD50 study of aqueous extract of A.sativum were achieved using standard biochemical methods.Twenty-four(24)male Wistar rats averagely weighing between 168–255 g were grouped into four of six animals in each steel-metal cage.Groups 1 and 2 served as normal and positive groups respectively.Rats in groups 2–4 were sensitized and challenged with a combination of OVA and LPS.Groups 3 and 4 were administered 250 and 500 mg/kg b.w of aqueous extract of A.sativum respectively for two weeks.The effect of aqueous extracts of A.sativum in OVA and LPS-induced asthma on alterations in differential white blood cells,inflammatory cytokines,some serum biochemical as well as histological indicators of experimental rats were assessed.Results:The aqueous extract of 600 g of plant material yielded 74.1 g accounting for 11.9%of sample material used.The result of the Phytochemical analysis showed higher number of glycosides,flavonoids and phenols.The animals displayed zero behavioral adverse reaction when administered the aqueous extract up to the highest dose of 5,000 mg/kg b.w.Administrations of aqueous extract of A.sativum remarkably(P<0.05;95%confidence intervals CI)declined the levels of neutrophils,eosinophils and total white blood cell count as opposed to the untreated group.Levels of interleukin 4(IL-4),interleukin 5(IL-5),interleukin 13(IL-13)and immunoglobulin E(IgE)of groups 3 and 4 had a significant(P<0.05;95%CI)varying percentage reduction(IL-4=39.78%,49.51%;IL-5=34.66%,40.05%;IL-13=31.96%,30.81%;33.45%,21.38%)respectively in comparison to group 2(untreated).The result showed a significantly(P<0.05,95%CI)declined malonaldehyde(MDA)concentration and elevated catalase,decreased glutathione concentration and superoxide dismutase activity of the treatment groups compared to the untreated.Serum liver function enzymes including alkaline phosphatase,alanine transaminase,and aspartate transaminase in the groups receiving aqueous extract of A.sativum exhibited a significant(P<0.05;95%CI)reduction in levels compared to group 2(untreated).Conclusion:Findings from this study indicated that aqueous extracts of A.sativum have the potential to improve asthma symptoms by decreasing inflammatory cytokines and mitigating oxidative stress.This effect could enhance the efficacy of conventional treatments such as inhaled corticosteroids,including cortisone,hydrocortisone,dexamethasone,and prednisone,as well as bronchodilators,leukotriene modifiers,and biologic therapies.Further studies need to be carried out on human subjects and also expanded to other respiratory disorders like Chronic obstructive pulmonary disease and Coronavirus Disease 2019.展开更多
BACKGROUND IgE plays a critical role in allergic inflammation and asthma pathogenesis.This study investigates the involvement of IgE cells in asthma exacerbation and evaluates the effectiveness of targeted interventio...BACKGROUND IgE plays a critical role in allergic inflammation and asthma pathogenesis.This study investigates the involvement of IgE cells in asthma exacerbation and evaluates the effectiveness of targeted interventions.AIM To evaluate the role of IgE in the exacerbation of allergic asthma and to determine the clinical efficacy of anti-IgE therapy in improving disease outcomes.Specifically,the study investigates changes in serum IgE levels,lung function,asthma control scores,and the frequency of acute exacerbations among patients receiving standard therapy with or without anti-IgE intervention.METHODS A total of 200 patients diagnosed with moderate to severe asthma were enrolled in this experimental study conducted from April 2024 to April 2025.Participants were randomized to receive either standard asthma therapy or therapy combined with anti-IgE agents.IgE levels and asthma control parameters were monitored.RESULTS Participants receiving anti-IgE treatment demonstrated a significant reduction in serum IgE levels(P<0.001),improved Forced expiratory volume in one second scores,and fewer exacerbation episodes compared to the control group.CONCLUSION IgE cells significantly contribute to asthma severity,and targeted therapy against IgE can improve disease outcomes.These findings underscore the importance of immunomodulatory strategies in asthma management.展开更多
In China,omalizumab is indicated for patients with moderate to severe persistent allergic asthma in whom symptoms remain inadequately controlled despite treatment with inhaled corticosteroids(ICS)in combination with l...In China,omalizumab is indicated for patients with moderate to severe persistent allergic asthma in whom symptoms remain inadequately controlled despite treatment with inhaled corticosteroids(ICS)in combination with long actingβ-agonists(LABA)(GINA step 3 or higher),and urticaria.We report a case of joint and Achilles tendon inflammatory reactions in a patient with Th2-type asthma receiving omalizumab treatment.An adult male presented with recurrent episodes of sneezing,rhinorrhea,wheezing,chest tightness,shortness of breath,and dyspnea.He exhibited allergies to multiple substances and demonstrated impaired lung function,ultimately being diagnosed with allergic rhinitis and asthma.Following initial treatment with ICS and LABA,his symptoms were initially controlled.However,as the disease progressed,the frequency of nocturnal attacks increased,and the incidence of attacks during the allergy season escalated,leading to a significant decline in lung function.Subsequently,he commenced subcutaneous injections of omalizumab at a dosage of 600 mg monthly.There was a partial improvement in the frequency of asthma attacks after two injections.Unfortunately,four days after the first treatment,he reported pain in the right Achilles tendon.Rheumatological screenings,including a five-item antinuclear antibody test and an 11-item autoantibody profile test,revealed no significant abnormalities.Ankle joint ultrasound indicated hyperechoic spots around the Achilles tendon with acoustic shadows,suggesting the presence of Achilles tendinopathy.Ten days later,the pain symptoms resolved spontaneously.Due to the sig-nificant improvement in asthma symptoms,omalizumab treatment continued,albeit with a dosage reduction to 300mg.After intermittent treatment over four sessions,asthma symptoms improved markedly,with the Asthma Control Test(ACT)score increasing from 14 to 20.Lung function improved from moderate obstruction to mild obstruction.The only drawback was the patient’s recurrent swelling,pain,and joint effusion in the joints(specifically the knee and ankle)during the treatment period.Omalizumab is an effective therapeutic option for the treatment of allergic asthma.Although the incidence of adverse events reported in current studies is low,there have been emerging reports of joint swelling,pain,and myalgia reactions in both children and adults receiving treatment for asthma and urticaria.Given the rarity and non-specific nature of these reactions,it is challenging to ascertain the true incidence rate.Previous reports have described symptoms that occur upon initiation of the medication,which can recur upon re-administration.While the factors that may increase the risk of joint inflammatory reactions to omalizumab remain to be elucidated,this case contributes to a deeper understanding of this adverse reaction associated with a well-tolerated and important therapeutic agent.展开更多
Objective:To analyze the clinical value of Pulmicort Respules inhalation combined with cetirizine in the treatment of pediatric asthma.Methods:From December 2023 to December 2024,82 children with asthma admitted to ou...Objective:To analyze the clinical value of Pulmicort Respules inhalation combined with cetirizine in the treatment of pediatric asthma.Methods:From December 2023 to December 2024,82 children with asthma admitted to our hospital were randomly divided into a control group and an observation group,with 41 cases in each group.The clinical symptom relief time(shortness of breath,cough,dyspnea,lung wheezing),lung function indicators(FEV1,FVC,FEV1/FVC),inflammatory indicators(TNF-α,IL-6,IL-8),and clinical treatment effects were analyzed in the two groups.Results:The relief time for shortness of breath,cough,dyspnea,and lung wheezing in the observation group was shorter than that in the control group(P<0.05).After treatment,compared with the control group,the levels of FEV1,FVC,FEV1/FVC,and treatment efficiency in the observation group were higher,while the levels of TNF-α,IL-6,and IL-8 were lower(P<0.05).Conclusion:The combination of Pulmicort Respules inhalation and cetirizine oral therapy for children with asthma can shorten the improvement time of clinical symptoms,inhibit inflammation,and improve lung function.展开更多
Asthma is the most common allergic disorder and represents a significant global public health problem.Strong evidence suggests a link between ascariasis and asthma.This study aims primarily to determine the prevalence...Asthma is the most common allergic disorder and represents a significant global public health problem.Strong evidence suggests a link between ascariasis and asthma.This study aims primarily to determine the prevalence of Ascaris lumbricoides infection among various risk factors,to assess blood parameters,levels of immunoglobulin E(IgE)and interleukin-4(IL-4),and to explore the relationship between ascariasis and asthma in affected individuals.The secondary objective is to examine a fractal-fractional mathematical model that describes the four stages of the life cycle of Ascaris infection,specifically within the framework of the Caputo-Fabrizio derivative.A case-control study was conducted that involved 270 individuals with asthma and 130 healthy controls,all of whom attended general hospitals in Duhok City,Iraq.Pulmonary function tests were performed using a micromedical spirometer.The presence of Ascaris lumbricoides antibodies-Immunoglobulin M(IgM),Immunoglobulin G(IgG),and Immunoglobulin E(IgE)-was detected using ELISA.Blood parameters were analyzed using a Coulter counter.The overall infection rate was(42.5%),with the highest rates observed among asthmatic men(70.0%)and rural residents(51.4%).Higher infection rates were also recorded among low-income individuals(64.3%)and those with frequent contact with the soil(58.6%).In particular,infected individuals exhibited a significant decrease in red blood cell count and hemoglobin concentration,while a marked increase in white blood cell count was recorded.In addition,levels of Immunoglobulin E(IgE)and interleukin-4 were significantly higher in the infected group compared to the controls.Effective disease awareness strategies that incorporate health education and preventive measures are needed.Exposure to Ascaris has been associated with reduced lung function and an increased risk of asthma.More research is required to elucidate the precise mechanisms that link Ascaris infection with asthma.Furthermore,the existence and uniqueness of solutions for the proposed model are investigated using the Krasnosel’skii and Banach fixed-point theorems.The Ulam-Hyers and Ulam-Hyers-Rassias stability types are explained within the framework of nonlinear analysis inŁp-space.Finally,an application is presented,including tabulated results and figures generated using MATLAB to illustrate the validity of the theoretical findings.展开更多
OBJECTIVE:To summarize the clinical efficacy characteristics of Suhuang Zhike capsule(苏黄止咳颗粒)and evaluate the incidence of adverse reactions in its broad clinical application.METHODS:This was a multicenter,prosp...OBJECTIVE:To summarize the clinical efficacy characteristics of Suhuang Zhike capsule(苏黄止咳颗粒)and evaluate the incidence of adverse reactions in its broad clinical application.METHODS:This was a multicenter,prospective,singlearm,open-label phase IV clinical trial.A total of 1100 patients diagnosed with cough variant asthma(CVA)and the Traditional Chinese Medicine(TCM)syndrome of wind evil invading the lung and lung Qi failing to propagate were planned for recruitment.Participants received Suhuang Zhike capsule orally,three capsules per dose,taken three times daily,for a treatment duration of 14 d.The primary outcome was the change in cough symptom scores from baseline to week 2.Cough severity was assessed twice daily.Additional evaluations included the rate and time of cough disappearance or basic disappearance rate,as well as the time of cough relief.TCM symptom scores were recorded at baseline and on days 7 and 14 of treatment.Safety assessments included monitoring for adverse events and conducting laboratory tests.RESULTS:A total of 1033 patients with CVA from 40 hospitals across China were enrolled in the study.Of these,1026 patients received the study medication and were included in the safety analysis.Fifty-four patients withdrew from the study,resulting in a drop-out rate of 5.23%.Treatment with Suhuang Zhike capsules significantly reduced cough symptom scores and improved cough-related symptoms in patients with CVA.The overall rate of cough disappearance or basic disappearance increased over the course of treatment,reaching 67.21%after 14 d.The median time of cough relief was 3 d,while the median time to cough disappearance or basic disappearance was 11 d.Additionally,the treatment led to reductions in TCM symptom scores and improvements in accompanying symptoms such as throat itching,expectoration,and shortness of breath.In terms of safety,no serious adverse events were reported.The incidence of related adverse events(AEs)was 2.24%(23 cases,30 events).The incidence of adverse reactions listed in the drug's instructions was 2.14%.Other related AEs not listed in the drug's instructions occurred in 0.39%of patients and included dizziness(0.19%),headache(0.10%),pruritus(0.10%),and palpitation(0.10%).CONCLUSION:Suhuang Zhike capsules demonstrated good efficacy and safety for the treatment of CVA.These findings offer valuable clinical evidence to support their broader application in routine clinical practice.展开更多
Background:Allergic eosinophilic asthma(EA)and eosinophilic granulomatosis with polyangiitis(EGPA)share significant overlaps in both epidemiology and pathogenesis,suggesting a potential link between the two con-dition...Background:Allergic eosinophilic asthma(EA)and eosinophilic granulomatosis with polyangiitis(EGPA)share significant overlaps in both epidemiology and pathogenesis,suggesting a potential link between the two con-ditions.Despite these associations,the underlying molecular and cellular mechanisms driving their connection remain poorly understood.Methods:We retrieved GSE143303 of EA and GSE144302 of EGPA from the GEO database and conducted dif-ferential expression analysis as well as functional enrichment analysis to identify differentially expressed genes(DEGs)and potential pathogenic pathways.A protein-protein interaction(PPI)network was generated using the STRING database.Key hub genes were determined through cytoHubba.We added two publicly reported EA and EGPA-related transcriptome datasets,GSE117038 and GSE119136,for mutual verification.Subsequent valida-tion was performed via immune infiltration assessment utilizing CIBERSORT.Results:In total,267 DEGs were identified,in which HSP90AA1,HSPA8,CCND1,RPS20,CD74,RPL5,RPS6,RHOA,RPS3A and FLT3LG are the top 10 hub genes,while the antigen processing and presentation pathway and leukocyte cell-cell adhesion pathway were the potential influential pathways.Increased naïve B cells and M1 type of Macrophages were detected in EA patients through immune infiltration analysis.Conclusions:Utilizing bioinformatics techniques,this study is the initial investigation to uncover the shared mechanisms involving the antigen processing and presentation pathway and leukocyte adhesion pathways in the progression of both EA and EGPA.It may offer potential biomarkers for future studies on the underlying path-ogenesis and treatment of EA and EGPA as well as eosinophilia related co-morbidities.展开更多
Objective Asthma imposes a significant global health burden.This study examines changes in the asthma-related disease burden from 1990 to 2021 and projects future burdens for 2050 under different scenarios.Methods Usi...Objective Asthma imposes a significant global health burden.This study examines changes in the asthma-related disease burden from 1990 to 2021 and projects future burdens for 2050 under different scenarios.Methods Using data from the Global Burden of Disease 2021 study,we analyzed asthma incidence,prevalence,mortality,and disability-adjusted life years(DALYs)from 1990 to 2021.We projected the disease burden for 2050 based on current trends and hypothetical scenarios in which all risk factors are controlled.Temporal trends in age-standardized incidence,prevalence,mortality,and DALY rates were explored using Annual Percent Change.Results In 2021,the age-standardized rates for asthma incidence,prevalence,mortality,and DALYs in China were 364.17 per 100,000(95%uncertainty interval[UI]:283.22-494.10),1,956.49 per 100,000(95%UI:1,566.68-2,491.87),1.47 per 100,000(95%UI:1.15-1.79),and 103.76 per 100,000(95%UI:72.50-145.46),respectively.A higher disease burden was observed among Chinese men and individuals aged 70 years or older.Compared to the current trend,a combined scenario involving improvements in environmental factors,behavioral and metabolic health,child nutrition,and vaccination resulted in a greater reduction in the disease burden caused by asthma.Conclusion Addressing modifiable risk factors is essential for further reducing the asthma-related disease burden.展开更多
Many studies have shown that the development of allergic asthma is associated with intestinal microbiota dysbiosis.Based on the gut-lung axis theory,probiotic intervention may be a potential strategy for respiratory d...Many studies have shown that the development of allergic asthma is associated with intestinal microbiota dysbiosis.Based on the gut-lung axis theory,probiotic intervention may be a potential strategy for respiratory diseases.Lacticaseibacillus paracasei K56 was reported to regulate gut microbiota in mice.However,its effect on allergic asthma has not been reported.In this study,we investigated the effect of the K56 on ovalbumininduced asthma and its possible mechanisms.Our results showed that K56 reduced asthma symptoms and inflammatory cell infiltration in the lung of asthmatic mice.And K56 regulated the differentiation of helper T cells in the lung and intestine.Results from 16S r RNA gene sequencing showed that K56 prophylaxis significantly elevated the richness of Akkermansia and Burkholderia.Meanwhile,K56 abrogated the decrease in the levels of short-chain fatty acids(SCFAs)in the feces.In addition,a rebound in the m RNA expression of the SCFA receptors was observed after K56 prophylaxis.Notably,the regulatory T cell(Treg)frequencies and the FFAR3 levels were positively correlated.These results suggest that K56 could attenuate asthma,possibly by modulating the intestinal microbiota and regulating Treg differentiation through SCFA metabolized.Our study showed that K56 may be used as a probiotic to prevent pulmonary inflammation and dysbiosis of the intestinal microbiota in allergic asthma.展开更多
Objective:To investigate the correlation between Mycoplasma pneumoniae infection and childhood asthma,and to explore the impact of Mp infection on airway inflammation and airway hyperresponsiveness in children with as...Objective:To investigate the correlation between Mycoplasma pneumoniae infection and childhood asthma,and to explore the impact of Mp infection on airway inflammation and airway hyperresponsiveness in children with asthma.Methods:58 children with bronchopneumonia admitted to the First People’s Hospital of Jintan,Changzhou from April 2024 to October 2024 were selected as the study subjects.The levels of cytokines IL-4,IL-17,TGF-β1,and INF-γ in the serum were compared between the MP group and non-MP group,as well as between the MP wheezing group and MP nonwheezing group.Results:The levels of IL-17 and IL-4 in the MP group were significantly higher than those in the non-MP group(P<0.05),while there was no statistically significant difference in the other indicators(P>0.05).Statistically significant differences in IL-17 and IL-4 were observed between the wheezing and non-wheezing groups(P<0.05),while there was no statistically significant difference in the other indicators(P>0.05).There was a significant difference in IL-17 among the groups(P<0.05).The difference in IL-17 between the MP group and non-MP group was significant(P<0.05),and the difference between the wheezing and non-wheezing groups was marginally significant(P<0.05).Conclusion:M.pneumoniae infection may be one of the risk factors for the onset of childhood asthma,but its mechanism remains unclear.Further research is needed to determine whether Mp infection can serve as a biomarker for childhood asthma and to elucidate its underlying mechanism.展开更多
Background:Dendritic cells(DCs)play a pivotal role in antigen presentation and regulating adaptive immune responses in asthma pathophysiology.However,the underlying molecular mechanisms remain incompletely understood....Background:Dendritic cells(DCs)play a pivotal role in antigen presentation and regulating adaptive immune responses in asthma pathophysiology.However,the underlying molecular mechanisms remain incompletely understood.Methods:Bioinformatics analysis of the GSE27011 dataset identified differentially expressed genes associated with pediatric asthma.An ovalbumin(OVA)-induced asthma mouse model and an Rfx5 knockdown model were established.RFX5 expression was assessed in DCs from patients with asthma and asthmatic mouse lung tissues using qRT-PCR,Western blotting,and immunohistochemistry.The regulatory effects of regulatory factor X5(RFX5)on histone deacetylase 2(HDAC2),class II major histocompatibility complex transactivator(CIITA),and major histocompatibility complex class II molecules(MHC II)expression,as well as its influence on lung tissue integrity,airway resistance,cytokine profiles,and immune cell infiltration,were analyzed.Co-immunoprecipitation and chromatin immunoprecipitation assays were performed to explore the interaction between RFX5 and HDAC2.Results:During asthma progression,RFX5 expression was upregulated,while HDAC2 levels were reduced in DCs.Rfx5 knockdown significantly alleviated lung pathology and inflammation,decreased granulocyte and lymphocyte counts,and lowered levels of pro-inflammatory cytokines interleukin 6(IL-6),tumor necrosis factor-alpha(TNF-α),and interleukin-1β(IL-1β).In contrast,the expression of anti-inflammatory cytokines such as interleukin 4(IL-4),interleukin 10(IL-10),interleukin 18(IL-18),and prostaglandin E2(PGE2)was elevated,along with an increase in CIITA and MHC II gene transcription.Further analysis revealed a direct association between HDAC2 and the RFX5 promoter region.Conclusion:During asthma pathogenesis,allergens may upregulate RFX5 expression in DCs,enhancing its interaction with HDAC2,thereby alleviating the HDAC2-mediated effect.This process promotes the transcription of MHC II-associated genes and facilitates antigen presentation,ultimately driving asthma initiation and progression.This study elucidates the role of the RFX5/HDAC2 signaling pathway in the regulation of antigen presentation in pediatric asthma.展开更多
Based on the number of asthmatic children in the Children's Hospital of Yulin City,the monitoring data of daily pollen concentration,and routine meteorological and environmental monitoring data of Yulin City from ...Based on the number of asthmatic children in the Children's Hospital of Yulin City,the monitoring data of daily pollen concentration,and routine meteorological and environmental monitoring data of Yulin City from 2020 to 2022,the meteorological and environmental conditions of a thunderstorm asthma event in Yulin City in northern Shaanxi on September 9,2022 were analyzed.The results show that the strong convective weather was accompanied by a strong thunderstorm,lightning,gusts,short-time heavy precipitation and small hail,and the convective activity lasted for nearly 7 h.The short-term abrupt change of allergenic substances such as artemisia pollen caused by lightning,gusts and precipitation,the sudden drop in temperature,the inversion near the surface and the stimulation of cold air were the key meteorological conditions for the subsequent outbreak of asthma.In early September in 2022,the daily average pollen concentration in Yulin City was up to 1067.9 particles/1000 mm^(2),which was 113.3%and 41.2%higher than that of the same period in 2021 and 2020,respectively.The day before the thunderstorm,the pollen concentration soared to 2680 particles/1000 mm^(2),reaching the maximum of the year.The synergistic effect of the thunderstorm event and the sharp increase in pollen concentration on the previous day provided the background of heavy pollen pollution for this outbreak of thunderstorm asthma.O_(3)concentration was consistently high on the day of thunderstorm and the day before,and the peaks of O_(3)and PM 10 concentration appeared subsequently in the afternoon of the day,which became the background of air pollution for the asthma outbreak.展开更多
Introduction: Work-aggravated asthma is pre-existing or concomitant asthma whose symptoms are aggravated by the work environment. The aim of this study was to determine the prevalence of this pathology and its associa...Introduction: Work-aggravated asthma is pre-existing or concomitant asthma whose symptoms are aggravated by the work environment. The aim of this study was to determine the prevalence of this pathology and its associated factors among bakery workers in Abidjan. Materials and Methods: This descriptive and analytical cross-sectional study was conducted over a period of four (4) months from 18 December 2019 to 18 April 2020. Two questionnaires were used, one on employees and the other on the indoor environment of bakeries. In addition, a spirometry test was performed on all bakery workers. Statistical analysis was performed using stata 15.1 software. Results: A total of 599 bakery employees, including bakers (59.73%), sales assistants/ cashiers (23.52%), cleaners (6.34%) and administrative staff (10.18%), were investigated. The mean age was 30.8 ± 8 years, with a sex ratio (M/F) = 2.2. Asthma symptoms were found in 95 (15.86%) employees, of whom 74 (77.9%) had work-related asthma and 11 (14.9%) had asthma aggravated by work. The factors associated with work-aggravated asthma were personal or family history of allergy or atopy [ORa = 3.75;CI95%: 1.56 - 8.93;p = 0.003], exposure to dust [ORa = 5.01;CI95%: 1.43 - 7.50;p = 0.011] and humidity level (60% - 70%) [ORa = 1.80;CI 95%: 0.99 - 3.28;p = 0.05]. Conclusion: Work-aggravated asthma is a reality in bakeries in Abidjan, with an estimated prevalence of 14.9%. Two of the three factors associated with this condition suggest a link with indoor air pollution. Combating air pollution in these establishments must therefore be a priority for the relevant authorities, in order to provide employees with a working environment that protects their health.展开更多
Objective Air pollution is a leading public health issue.This study investigated the effect of air quality and pollutants on pulmonary function and inflammation in patients with asthma in Shanghai.Methods The study mo...Objective Air pollution is a leading public health issue.This study investigated the effect of air quality and pollutants on pulmonary function and inflammation in patients with asthma in Shanghai.Methods The study monitored 27 asthma outpatients for a year,collecting data on weather,patient self-management[daily asthma diary,peak expiratory flow(PEF)monitoring,medication usage],spirometry and serum markers.To explore the potential mechanisms of any effects,asthmatic mice induced by ovalbumin(OVA)were exposed to PM_(2.5).Results Statistical and correlational analyses revealed that air pollutants have both acute and chronic effects on asthma.Acute exposure showed a correlation between PEF and levels of ozone(O_(3))and nitrogen dioxide(NO_(2)).Chronic exposure indicated that interleukin-5(IL-5)and interleukin-13(IL-13)levels correlated with PM_(2.5)and PM_(10)concentrations.In asthmatic mouse models,exposure to PM_(2.5)increased cytokine levels and worsened lung function.Additionally,PM_(2.5)exposure inhibited cell proliferation by blocking the NF-κB and ERK phosphorylation pathways.Conclusion Ambient air pollutants exacerbate asthma by worsening lung function and enhancing Th2-mediated inflammation.Specifically,PM_(2.5)significantly contributes to these adverse effects.Further research is needed to elucidate the mechanisms by which PM_(2.5)impacts asthma.展开更多
BACKGROUND Pediatric asthma is a significant public health issue that impacts the quality of life of children globally.Traditional management approaches focus on symptom control and medication adherence but often over...BACKGROUND Pediatric asthma is a significant public health issue that impacts the quality of life of children globally.Traditional management approaches focus on symptom control and medication adherence but often overlook the comprehensive educational needs of patients and their families.A multifaceted health education approach may offer a more holistic strategy in managing pediatric asthma,especially in outpatient settings.AIM To evaluate the efficacy of a comprehensive health education strategy in improving disease management,medication adherence,and quality of life among children with asthma in outpatient settings.METHODS In total,100 pediatric patients with severe asthma were enrolled from January 2021 to November 2022 and randomly allocated to a control group(n=50)or an observation group(n=50).The control group received standard nursing care,including basic nursing interventions and health education upon admission.In contrast,the observation group was exposed to a broad spectrum of health education methodologies,including internet-based hospital systems,social media channels,one-on-one verbal education,informational brochures,slide present ations,telephone check-ins,animated videos,and illustrated health education manuals.Data on asthma management knowledge,symptom control,quality of life[St.George’s Respiratory Questionnaire(SGRQ)],treatment adherence,and nursing satisfaction were collected and analyzed.RESULTS The scores of the observation group in knowledge areas,such as medication,home care,disease understanding,symptom management,prevention strategies,and nutritional guidance,were significantly higher than those of the control group(P<0.05).In addition,the observation group exhibited greater symptom control,improved quality of life based on their SGRQ scores,and higher treatment adherence post-intervention(P<0.05).Nursing satisfaction was also rated higher in the observation group across all evaluated areas(P<0.05).CONCLUSION Implementing a diversified health education approach in pediatric asthma management significantly enhances disease understanding,symptom management,and treatment adherence,leading to improved quality of life for affected children.These findings underscore the importance of multifaceted clinical health education in augmenting disease awareness and facilitating continuous improvements in asthma control rates,highlighting the potential benefits of incorporating comprehensive educational strategies into pediatric asthma care protocols.展开更多
Asthma is a widespread public health concern,with an increasing incidence.Despite the implementation of current treatment strategies,asthma control,particularly for severe cases,remains suboptimal.Recent research has ...Asthma is a widespread public health concern,with an increasing incidence.Despite the implementation of current treatment strategies,asthma control,particularly for severe cases,remains suboptimal.Recent research has revealed the encouraging prospects of extracellular vesicles(EVs)secreted by mesenchymal stem cells(MSCs)as a viable therapeutic option for alleviating asthma symptoms.Therefore,the present review aims to provide an overview of the current progress and the therapeutic mechanisms of using MSC-derived EVs(MSC-EVs)for asthma treatment.Additionally,different administration approaches for EVs and their impacts on biodistribution and the curative outcomes of EVs are summarized.Notably,the potential benefits of nebulized inhalation of MSC-EVs are addressed.Also,the possibilities and challenges of using MSC-EVs for asthma treatment in clinics are highlighted.Overall,this reviewis intended to give newinsight into the utilization of MSC-EVs as a potential biological drug for asthma treatment.展开更多
文摘BACKGROUND The relationship between diabetes mellitus(DM)and asthma is complex and can impact disease trajectories.AIM To explore the bidirectional influences between the two conditions on clinical outcomes and disease control.METHODS We systematically reviewed the literature on the relationship between DM and asthma,focusing on their impacts,mechanisms,and therapeutic implications.Various studies were assessed,which investigated the effect of glycemic control on asthma outcomes,lung function,and exacerbations.The study highlighted the role of specific diabetes medications in managing asthma.RESULTS The results showed that poor glycemic control in diabetes can exacerbate asthma,increase hospitalizations,and reduce lung function.Conversely,severe asthma,especially in obese individuals,can complicate diabetes management and make glycemic control more difficult.The diabetes-associated mechanisms,such as inflammation,microangiopathy,and oxidative stress,can exacerbate asthma and decrease lung function.Some diabetes medications exhibit anti-inflammatory effects that show promise in mitigating asthma exacerbations.CONCLUSION The complex interrelationship between diabetes and asthma suggests bidirectional influences that affect disease course and outcomes.Inflammation and microvascular complications associated with diabetes may worsen asthma outcomes,while asthma severity,especially in obese individuals,complicates diabetes control.However,the current research has limitations,and more diverse longitudinal studies are required to establish causal relationships and identify effective treatment strategies for individuals with both conditions.
基金supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(2021-I2M-1-049)Noncommunicable Chronic Diseases-National Science and Technology Major Project(2024ZD0529800).
文摘Bronchial asthma is divided into type 2 and non-type 2 asthma based on the immunopathogenesis.Type 2 inflammation is an inflammation mediated by T helper 2 cells,group 2 innate lymphoid cells and sustained by a specific subset of cytokines.In recent years,type 2 asthma has become the research hotspot in the field of asthma.For type 2 asthma,targeted therapies have become effective treatments and widely used in clinical practice.In order to further understand the progress of biologic drugs for bronchial asthma,as well as the disease outcomes in patients with type 2 asthma,and improve asthma control and remission,this article reviewed the progress and achievements of biologic drugs for asthma from May 1,2023 to April 30,2024,providing clinical perspective for the choosing appropriate targeted treatment of asthma.It also highlights selected poster pre-sentations from the ATS 2024 Annual Meeting to provide clinical insights for choosing appropriate targeted treatments for Type 2 asthma.
基金the Joint Innovation Project Funds of Huaqiao University,No.2022YX001.
文摘The global incidence of asthma,a leading respiratory disorder affecting more than 235 million people,has dramatically increased in recent years.Characterized by chronic airway inflammation and an imbalanced response to airborne irritants,this chronic condition is associated with elevated levels of inflammatory factors and symptoms such as dyspnea,cough,wheezing,and chest tightness.Conventional asthma therapies,such as corticosteroids,long-actingβ-agonists,and antiinflammatory agents,often evoke diverse adverse reactions and fail to reduce symptoms and hospitalization rates over the long term effectively.These limitations have prompted researchers to explore innovative therapeutic strategies,including stem cell-related interventions,offering hope to those afflicted with this incurable disease.In this review,we describe the characteristics of stem cells and critically assess the potential and challenges of stem cell-based therapies to improve disease management and treatment outcomes for asthma and other diseases.
文摘BACKGROUND Diffuse panbronchiolitis(DPB)is a rare,chronic inflammatory lung disease mar-ked by chronic cough,breathlessness,and preceding sinusitis.Symptoms often persist for years and can be misdiagnosed as asthma,particularly in children.This report describes a DPB case resolved with long-term azithromycin therapy,em-phasizing the need for a timely and accurate diagnosis.CASE SUMMARY A 12-year-old girl,diagnosed with asthma at age five and managed with inhaled corticosteroids and long-acting beta-2 agonists,developed a history of chronic productive cough and chronic sinusitis for a year.On examination,she exhibited wheezing and coarse crackles.Despite receiving treatment for an asthma exacer-bation,her symptoms did not improve.A chest X-ray revealed reticulonodular infiltration in both lower lungs,prompting further evaluation with high-resolu-tion computed tomography(HRCT).The HRCT confirmed centrilobular nodule opacities,a'tree-in-bud'pattern,and non-tapering bronchi,suggesting DPB.Elevated cold hemagglutinin titers at 128 further supported the diagnosis.Her cough and sinusitis resolved within a month after starting azithromycin therapy,chosen for its anti-inflammatory and immunomodulatory effects.Follow-up HRCT scans after 1 year of continuous treatment showed complete normalization.CONCLUSION This case highlights the importance of early diagnosis and prompt treatment in achieving favorable outcomes for DPB.
文摘Background:To appraise the ameliorative potentials of Allium sativum aqueous extract in ovalbumin(OVA)-lipopolysaccharide(LPS)-induced asthma.Methods:Extraction,phytochemical analysis,determination of bioactive compounds and LD50 study of aqueous extract of A.sativum were achieved using standard biochemical methods.Twenty-four(24)male Wistar rats averagely weighing between 168–255 g were grouped into four of six animals in each steel-metal cage.Groups 1 and 2 served as normal and positive groups respectively.Rats in groups 2–4 were sensitized and challenged with a combination of OVA and LPS.Groups 3 and 4 were administered 250 and 500 mg/kg b.w of aqueous extract of A.sativum respectively for two weeks.The effect of aqueous extracts of A.sativum in OVA and LPS-induced asthma on alterations in differential white blood cells,inflammatory cytokines,some serum biochemical as well as histological indicators of experimental rats were assessed.Results:The aqueous extract of 600 g of plant material yielded 74.1 g accounting for 11.9%of sample material used.The result of the Phytochemical analysis showed higher number of glycosides,flavonoids and phenols.The animals displayed zero behavioral adverse reaction when administered the aqueous extract up to the highest dose of 5,000 mg/kg b.w.Administrations of aqueous extract of A.sativum remarkably(P<0.05;95%confidence intervals CI)declined the levels of neutrophils,eosinophils and total white blood cell count as opposed to the untreated group.Levels of interleukin 4(IL-4),interleukin 5(IL-5),interleukin 13(IL-13)and immunoglobulin E(IgE)of groups 3 and 4 had a significant(P<0.05;95%CI)varying percentage reduction(IL-4=39.78%,49.51%;IL-5=34.66%,40.05%;IL-13=31.96%,30.81%;33.45%,21.38%)respectively in comparison to group 2(untreated).The result showed a significantly(P<0.05,95%CI)declined malonaldehyde(MDA)concentration and elevated catalase,decreased glutathione concentration and superoxide dismutase activity of the treatment groups compared to the untreated.Serum liver function enzymes including alkaline phosphatase,alanine transaminase,and aspartate transaminase in the groups receiving aqueous extract of A.sativum exhibited a significant(P<0.05;95%CI)reduction in levels compared to group 2(untreated).Conclusion:Findings from this study indicated that aqueous extracts of A.sativum have the potential to improve asthma symptoms by decreasing inflammatory cytokines and mitigating oxidative stress.This effect could enhance the efficacy of conventional treatments such as inhaled corticosteroids,including cortisone,hydrocortisone,dexamethasone,and prednisone,as well as bronchodilators,leukotriene modifiers,and biologic therapies.Further studies need to be carried out on human subjects and also expanded to other respiratory disorders like Chronic obstructive pulmonary disease and Coronavirus Disease 2019.
文摘BACKGROUND IgE plays a critical role in allergic inflammation and asthma pathogenesis.This study investigates the involvement of IgE cells in asthma exacerbation and evaluates the effectiveness of targeted interventions.AIM To evaluate the role of IgE in the exacerbation of allergic asthma and to determine the clinical efficacy of anti-IgE therapy in improving disease outcomes.Specifically,the study investigates changes in serum IgE levels,lung function,asthma control scores,and the frequency of acute exacerbations among patients receiving standard therapy with or without anti-IgE intervention.METHODS A total of 200 patients diagnosed with moderate to severe asthma were enrolled in this experimental study conducted from April 2024 to April 2025.Participants were randomized to receive either standard asthma therapy or therapy combined with anti-IgE agents.IgE levels and asthma control parameters were monitored.RESULTS Participants receiving anti-IgE treatment demonstrated a significant reduction in serum IgE levels(P<0.001),improved Forced expiratory volume in one second scores,and fewer exacerbation episodes compared to the control group.CONCLUSION IgE cells significantly contribute to asthma severity,and targeted therapy against IgE can improve disease outcomes.These findings underscore the importance of immunomodulatory strategies in asthma management.
文摘In China,omalizumab is indicated for patients with moderate to severe persistent allergic asthma in whom symptoms remain inadequately controlled despite treatment with inhaled corticosteroids(ICS)in combination with long actingβ-agonists(LABA)(GINA step 3 or higher),and urticaria.We report a case of joint and Achilles tendon inflammatory reactions in a patient with Th2-type asthma receiving omalizumab treatment.An adult male presented with recurrent episodes of sneezing,rhinorrhea,wheezing,chest tightness,shortness of breath,and dyspnea.He exhibited allergies to multiple substances and demonstrated impaired lung function,ultimately being diagnosed with allergic rhinitis and asthma.Following initial treatment with ICS and LABA,his symptoms were initially controlled.However,as the disease progressed,the frequency of nocturnal attacks increased,and the incidence of attacks during the allergy season escalated,leading to a significant decline in lung function.Subsequently,he commenced subcutaneous injections of omalizumab at a dosage of 600 mg monthly.There was a partial improvement in the frequency of asthma attacks after two injections.Unfortunately,four days after the first treatment,he reported pain in the right Achilles tendon.Rheumatological screenings,including a five-item antinuclear antibody test and an 11-item autoantibody profile test,revealed no significant abnormalities.Ankle joint ultrasound indicated hyperechoic spots around the Achilles tendon with acoustic shadows,suggesting the presence of Achilles tendinopathy.Ten days later,the pain symptoms resolved spontaneously.Due to the sig-nificant improvement in asthma symptoms,omalizumab treatment continued,albeit with a dosage reduction to 300mg.After intermittent treatment over four sessions,asthma symptoms improved markedly,with the Asthma Control Test(ACT)score increasing from 14 to 20.Lung function improved from moderate obstruction to mild obstruction.The only drawback was the patient’s recurrent swelling,pain,and joint effusion in the joints(specifically the knee and ankle)during the treatment period.Omalizumab is an effective therapeutic option for the treatment of allergic asthma.Although the incidence of adverse events reported in current studies is low,there have been emerging reports of joint swelling,pain,and myalgia reactions in both children and adults receiving treatment for asthma and urticaria.Given the rarity and non-specific nature of these reactions,it is challenging to ascertain the true incidence rate.Previous reports have described symptoms that occur upon initiation of the medication,which can recur upon re-administration.While the factors that may increase the risk of joint inflammatory reactions to omalizumab remain to be elucidated,this case contributes to a deeper understanding of this adverse reaction associated with a well-tolerated and important therapeutic agent.
文摘Objective:To analyze the clinical value of Pulmicort Respules inhalation combined with cetirizine in the treatment of pediatric asthma.Methods:From December 2023 to December 2024,82 children with asthma admitted to our hospital were randomly divided into a control group and an observation group,with 41 cases in each group.The clinical symptom relief time(shortness of breath,cough,dyspnea,lung wheezing),lung function indicators(FEV1,FVC,FEV1/FVC),inflammatory indicators(TNF-α,IL-6,IL-8),and clinical treatment effects were analyzed in the two groups.Results:The relief time for shortness of breath,cough,dyspnea,and lung wheezing in the observation group was shorter than that in the control group(P<0.05).After treatment,compared with the control group,the levels of FEV1,FVC,FEV1/FVC,and treatment efficiency in the observation group were higher,while the levels of TNF-α,IL-6,and IL-8 were lower(P<0.05).Conclusion:The combination of Pulmicort Respules inhalation and cetirizine oral therapy for children with asthma can shorten the improvement time of clinical symptoms,inhibit inflammation,and improve lung function.
文摘Asthma is the most common allergic disorder and represents a significant global public health problem.Strong evidence suggests a link between ascariasis and asthma.This study aims primarily to determine the prevalence of Ascaris lumbricoides infection among various risk factors,to assess blood parameters,levels of immunoglobulin E(IgE)and interleukin-4(IL-4),and to explore the relationship between ascariasis and asthma in affected individuals.The secondary objective is to examine a fractal-fractional mathematical model that describes the four stages of the life cycle of Ascaris infection,specifically within the framework of the Caputo-Fabrizio derivative.A case-control study was conducted that involved 270 individuals with asthma and 130 healthy controls,all of whom attended general hospitals in Duhok City,Iraq.Pulmonary function tests were performed using a micromedical spirometer.The presence of Ascaris lumbricoides antibodies-Immunoglobulin M(IgM),Immunoglobulin G(IgG),and Immunoglobulin E(IgE)-was detected using ELISA.Blood parameters were analyzed using a Coulter counter.The overall infection rate was(42.5%),with the highest rates observed among asthmatic men(70.0%)and rural residents(51.4%).Higher infection rates were also recorded among low-income individuals(64.3%)and those with frequent contact with the soil(58.6%).In particular,infected individuals exhibited a significant decrease in red blood cell count and hemoglobin concentration,while a marked increase in white blood cell count was recorded.In addition,levels of Immunoglobulin E(IgE)and interleukin-4 were significantly higher in the infected group compared to the controls.Effective disease awareness strategies that incorporate health education and preventive measures are needed.Exposure to Ascaris has been associated with reduced lung function and an increased risk of asthma.More research is required to elucidate the precise mechanisms that link Ascaris infection with asthma.Furthermore,the existence and uniqueness of solutions for the proposed model are investigated using the Krasnosel’skii and Banach fixed-point theorems.The Ulam-Hyers and Ulam-Hyers-Rassias stability types are explained within the framework of nonlinear analysis inŁp-space.Finally,an application is presented,including tabulated results and figures generated using MATLAB to illustrate the validity of the theoretical findings.
基金Supported by the Inheritance and Innovation of Traditional Chinese Medicine"Hundred Million"Talent Project(Qihuang Project)(2019-QTL-003)。
文摘OBJECTIVE:To summarize the clinical efficacy characteristics of Suhuang Zhike capsule(苏黄止咳颗粒)and evaluate the incidence of adverse reactions in its broad clinical application.METHODS:This was a multicenter,prospective,singlearm,open-label phase IV clinical trial.A total of 1100 patients diagnosed with cough variant asthma(CVA)and the Traditional Chinese Medicine(TCM)syndrome of wind evil invading the lung and lung Qi failing to propagate were planned for recruitment.Participants received Suhuang Zhike capsule orally,three capsules per dose,taken three times daily,for a treatment duration of 14 d.The primary outcome was the change in cough symptom scores from baseline to week 2.Cough severity was assessed twice daily.Additional evaluations included the rate and time of cough disappearance or basic disappearance rate,as well as the time of cough relief.TCM symptom scores were recorded at baseline and on days 7 and 14 of treatment.Safety assessments included monitoring for adverse events and conducting laboratory tests.RESULTS:A total of 1033 patients with CVA from 40 hospitals across China were enrolled in the study.Of these,1026 patients received the study medication and were included in the safety analysis.Fifty-four patients withdrew from the study,resulting in a drop-out rate of 5.23%.Treatment with Suhuang Zhike capsules significantly reduced cough symptom scores and improved cough-related symptoms in patients with CVA.The overall rate of cough disappearance or basic disappearance increased over the course of treatment,reaching 67.21%after 14 d.The median time of cough relief was 3 d,while the median time to cough disappearance or basic disappearance was 11 d.Additionally,the treatment led to reductions in TCM symptom scores and improvements in accompanying symptoms such as throat itching,expectoration,and shortness of breath.In terms of safety,no serious adverse events were reported.The incidence of related adverse events(AEs)was 2.24%(23 cases,30 events).The incidence of adverse reactions listed in the drug's instructions was 2.14%.Other related AEs not listed in the drug's instructions occurred in 0.39%of patients and included dizziness(0.19%),headache(0.10%),pruritus(0.10%),and palpitation(0.10%).CONCLUSION:Suhuang Zhike capsules demonstrated good efficacy and safety for the treatment of CVA.These findings offer valuable clinical evidence to support their broader application in routine clinical practice.
基金funded by National Natural Science Foundation of China(NO.82370083).
文摘Background:Allergic eosinophilic asthma(EA)and eosinophilic granulomatosis with polyangiitis(EGPA)share significant overlaps in both epidemiology and pathogenesis,suggesting a potential link between the two con-ditions.Despite these associations,the underlying molecular and cellular mechanisms driving their connection remain poorly understood.Methods:We retrieved GSE143303 of EA and GSE144302 of EGPA from the GEO database and conducted dif-ferential expression analysis as well as functional enrichment analysis to identify differentially expressed genes(DEGs)and potential pathogenic pathways.A protein-protein interaction(PPI)network was generated using the STRING database.Key hub genes were determined through cytoHubba.We added two publicly reported EA and EGPA-related transcriptome datasets,GSE117038 and GSE119136,for mutual verification.Subsequent valida-tion was performed via immune infiltration assessment utilizing CIBERSORT.Results:In total,267 DEGs were identified,in which HSP90AA1,HSPA8,CCND1,RPS20,CD74,RPL5,RPS6,RHOA,RPS3A and FLT3LG are the top 10 hub genes,while the antigen processing and presentation pathway and leukocyte cell-cell adhesion pathway were the potential influential pathways.Increased naïve B cells and M1 type of Macrophages were detected in EA patients through immune infiltration analysis.Conclusions:Utilizing bioinformatics techniques,this study is the initial investigation to uncover the shared mechanisms involving the antigen processing and presentation pathway and leukocyte adhesion pathways in the progression of both EA and EGPA.It may offer potential biomarkers for future studies on the underlying path-ogenesis and treatment of EA and EGPA as well as eosinophilia related co-morbidities.
文摘Objective Asthma imposes a significant global health burden.This study examines changes in the asthma-related disease burden from 1990 to 2021 and projects future burdens for 2050 under different scenarios.Methods Using data from the Global Burden of Disease 2021 study,we analyzed asthma incidence,prevalence,mortality,and disability-adjusted life years(DALYs)from 1990 to 2021.We projected the disease burden for 2050 based on current trends and hypothetical scenarios in which all risk factors are controlled.Temporal trends in age-standardized incidence,prevalence,mortality,and DALY rates were explored using Annual Percent Change.Results In 2021,the age-standardized rates for asthma incidence,prevalence,mortality,and DALYs in China were 364.17 per 100,000(95%uncertainty interval[UI]:283.22-494.10),1,956.49 per 100,000(95%UI:1,566.68-2,491.87),1.47 per 100,000(95%UI:1.15-1.79),and 103.76 per 100,000(95%UI:72.50-145.46),respectively.A higher disease burden was observed among Chinese men and individuals aged 70 years or older.Compared to the current trend,a combined scenario involving improvements in environmental factors,behavioral and metabolic health,child nutrition,and vaccination resulted in a greater reduction in the disease burden caused by asthma.Conclusion Addressing modifiable risk factors is essential for further reducing the asthma-related disease burden.
基金supported by grants from the National Natural Science Foundation of China(82174113,81473656)National Center of Technology Innovation for Dairy(No.2023-JSGG-15)。
文摘Many studies have shown that the development of allergic asthma is associated with intestinal microbiota dysbiosis.Based on the gut-lung axis theory,probiotic intervention may be a potential strategy for respiratory diseases.Lacticaseibacillus paracasei K56 was reported to regulate gut microbiota in mice.However,its effect on allergic asthma has not been reported.In this study,we investigated the effect of the K56 on ovalbumininduced asthma and its possible mechanisms.Our results showed that K56 reduced asthma symptoms and inflammatory cell infiltration in the lung of asthmatic mice.And K56 regulated the differentiation of helper T cells in the lung and intestine.Results from 16S r RNA gene sequencing showed that K56 prophylaxis significantly elevated the richness of Akkermansia and Burkholderia.Meanwhile,K56 abrogated the decrease in the levels of short-chain fatty acids(SCFAs)in the feces.In addition,a rebound in the m RNA expression of the SCFA receptors was observed after K56 prophylaxis.Notably,the regulatory T cell(Treg)frequencies and the FFAR3 levels were positively correlated.These results suggest that K56 could attenuate asthma,possibly by modulating the intestinal microbiota and regulating Treg differentiation through SCFA metabolized.Our study showed that K56 may be used as a probiotic to prevent pulmonary inflammation and dysbiosis of the intestinal microbiota in allergic asthma.
基金Research Project of Jiangsu Maternal and Child Health Care Association(Project No.:FX202335)。
文摘Objective:To investigate the correlation between Mycoplasma pneumoniae infection and childhood asthma,and to explore the impact of Mp infection on airway inflammation and airway hyperresponsiveness in children with asthma.Methods:58 children with bronchopneumonia admitted to the First People’s Hospital of Jintan,Changzhou from April 2024 to October 2024 were selected as the study subjects.The levels of cytokines IL-4,IL-17,TGF-β1,and INF-γ in the serum were compared between the MP group and non-MP group,as well as between the MP wheezing group and MP nonwheezing group.Results:The levels of IL-17 and IL-4 in the MP group were significantly higher than those in the non-MP group(P<0.05),while there was no statistically significant difference in the other indicators(P>0.05).Statistically significant differences in IL-17 and IL-4 were observed between the wheezing and non-wheezing groups(P<0.05),while there was no statistically significant difference in the other indicators(P>0.05).There was a significant difference in IL-17 among the groups(P<0.05).The difference in IL-17 between the MP group and non-MP group was significant(P<0.05),and the difference between the wheezing and non-wheezing groups was marginally significant(P<0.05).Conclusion:M.pneumoniae infection may be one of the risk factors for the onset of childhood asthma,but its mechanism remains unclear.Further research is needed to determine whether Mp infection can serve as a biomarker for childhood asthma and to elucidate its underlying mechanism.
基金supported by the 2021 Jiangxi Provincial Department of Science and Technology Applied Research Cultivation Plan Project(No.20212BAG70005,Yahui Wu)2021 Science and Technology Special Project and Social Development Project in Ji’an City,Jiangxi Province(No.20211-025242,Yahui Wu).
文摘Background:Dendritic cells(DCs)play a pivotal role in antigen presentation and regulating adaptive immune responses in asthma pathophysiology.However,the underlying molecular mechanisms remain incompletely understood.Methods:Bioinformatics analysis of the GSE27011 dataset identified differentially expressed genes associated with pediatric asthma.An ovalbumin(OVA)-induced asthma mouse model and an Rfx5 knockdown model were established.RFX5 expression was assessed in DCs from patients with asthma and asthmatic mouse lung tissues using qRT-PCR,Western blotting,and immunohistochemistry.The regulatory effects of regulatory factor X5(RFX5)on histone deacetylase 2(HDAC2),class II major histocompatibility complex transactivator(CIITA),and major histocompatibility complex class II molecules(MHC II)expression,as well as its influence on lung tissue integrity,airway resistance,cytokine profiles,and immune cell infiltration,were analyzed.Co-immunoprecipitation and chromatin immunoprecipitation assays were performed to explore the interaction between RFX5 and HDAC2.Results:During asthma progression,RFX5 expression was upregulated,while HDAC2 levels were reduced in DCs.Rfx5 knockdown significantly alleviated lung pathology and inflammation,decreased granulocyte and lymphocyte counts,and lowered levels of pro-inflammatory cytokines interleukin 6(IL-6),tumor necrosis factor-alpha(TNF-α),and interleukin-1β(IL-1β).In contrast,the expression of anti-inflammatory cytokines such as interleukin 4(IL-4),interleukin 10(IL-10),interleukin 18(IL-18),and prostaglandin E2(PGE2)was elevated,along with an increase in CIITA and MHC II gene transcription.Further analysis revealed a direct association between HDAC2 and the RFX5 promoter region.Conclusion:During asthma pathogenesis,allergens may upregulate RFX5 expression in DCs,enhancing its interaction with HDAC2,thereby alleviating the HDAC2-mediated effect.This process promotes the transcription of MHC II-associated genes and facilitates antigen presentation,ultimately driving asthma initiation and progression.This study elucidates the role of the RFX5/HDAC2 signaling pathway in the regulation of antigen presentation in pediatric asthma.
基金Supported by the People's Government of Yulin City(2023-SF-09)Yulin Meteorological Bureau(2024Y-02)Open Research Fund Project of Key Laboratory of Ecological Environment and Meteorology in the Qinling Mountains and Loess Plateau(2022Y-21).
文摘Based on the number of asthmatic children in the Children's Hospital of Yulin City,the monitoring data of daily pollen concentration,and routine meteorological and environmental monitoring data of Yulin City from 2020 to 2022,the meteorological and environmental conditions of a thunderstorm asthma event in Yulin City in northern Shaanxi on September 9,2022 were analyzed.The results show that the strong convective weather was accompanied by a strong thunderstorm,lightning,gusts,short-time heavy precipitation and small hail,and the convective activity lasted for nearly 7 h.The short-term abrupt change of allergenic substances such as artemisia pollen caused by lightning,gusts and precipitation,the sudden drop in temperature,the inversion near the surface and the stimulation of cold air were the key meteorological conditions for the subsequent outbreak of asthma.In early September in 2022,the daily average pollen concentration in Yulin City was up to 1067.9 particles/1000 mm^(2),which was 113.3%and 41.2%higher than that of the same period in 2021 and 2020,respectively.The day before the thunderstorm,the pollen concentration soared to 2680 particles/1000 mm^(2),reaching the maximum of the year.The synergistic effect of the thunderstorm event and the sharp increase in pollen concentration on the previous day provided the background of heavy pollen pollution for this outbreak of thunderstorm asthma.O_(3)concentration was consistently high on the day of thunderstorm and the day before,and the peaks of O_(3)and PM 10 concentration appeared subsequently in the afternoon of the day,which became the background of air pollution for the asthma outbreak.
文摘Introduction: Work-aggravated asthma is pre-existing or concomitant asthma whose symptoms are aggravated by the work environment. The aim of this study was to determine the prevalence of this pathology and its associated factors among bakery workers in Abidjan. Materials and Methods: This descriptive and analytical cross-sectional study was conducted over a period of four (4) months from 18 December 2019 to 18 April 2020. Two questionnaires were used, one on employees and the other on the indoor environment of bakeries. In addition, a spirometry test was performed on all bakery workers. Statistical analysis was performed using stata 15.1 software. Results: A total of 599 bakery employees, including bakers (59.73%), sales assistants/ cashiers (23.52%), cleaners (6.34%) and administrative staff (10.18%), were investigated. The mean age was 30.8 ± 8 years, with a sex ratio (M/F) = 2.2. Asthma symptoms were found in 95 (15.86%) employees, of whom 74 (77.9%) had work-related asthma and 11 (14.9%) had asthma aggravated by work. The factors associated with work-aggravated asthma were personal or family history of allergy or atopy [ORa = 3.75;CI95%: 1.56 - 8.93;p = 0.003], exposure to dust [ORa = 5.01;CI95%: 1.43 - 7.50;p = 0.011] and humidity level (60% - 70%) [ORa = 1.80;CI 95%: 0.99 - 3.28;p = 0.05]. Conclusion: Work-aggravated asthma is a reality in bakeries in Abidjan, with an estimated prevalence of 14.9%. Two of the three factors associated with this condition suggest a link with indoor air pollution. Combating air pollution in these establishments must therefore be a priority for the relevant authorities, in order to provide employees with a working environment that protects their health.
基金supported by Shanghai Science and Technology Commission with Project(No.14411951100,No.21s31900400)。
文摘Objective Air pollution is a leading public health issue.This study investigated the effect of air quality and pollutants on pulmonary function and inflammation in patients with asthma in Shanghai.Methods The study monitored 27 asthma outpatients for a year,collecting data on weather,patient self-management[daily asthma diary,peak expiratory flow(PEF)monitoring,medication usage],spirometry and serum markers.To explore the potential mechanisms of any effects,asthmatic mice induced by ovalbumin(OVA)were exposed to PM_(2.5).Results Statistical and correlational analyses revealed that air pollutants have both acute and chronic effects on asthma.Acute exposure showed a correlation between PEF and levels of ozone(O_(3))and nitrogen dioxide(NO_(2)).Chronic exposure indicated that interleukin-5(IL-5)and interleukin-13(IL-13)levels correlated with PM_(2.5)and PM_(10)concentrations.In asthmatic mouse models,exposure to PM_(2.5)increased cytokine levels and worsened lung function.Additionally,PM_(2.5)exposure inhibited cell proliferation by blocking the NF-κB and ERK phosphorylation pathways.Conclusion Ambient air pollutants exacerbate asthma by worsening lung function and enhancing Th2-mediated inflammation.Specifically,PM_(2.5)significantly contributes to these adverse effects.Further research is needed to elucidate the mechanisms by which PM_(2.5)impacts asthma.
基金Self-raised project of Health and Health Commission of Guangxi Zhuang Autonomous Region,NO.Z-A20220429Guangxi Natural Science Foundation,NO.2020JJA140193.
文摘BACKGROUND Pediatric asthma is a significant public health issue that impacts the quality of life of children globally.Traditional management approaches focus on symptom control and medication adherence but often overlook the comprehensive educational needs of patients and their families.A multifaceted health education approach may offer a more holistic strategy in managing pediatric asthma,especially in outpatient settings.AIM To evaluate the efficacy of a comprehensive health education strategy in improving disease management,medication adherence,and quality of life among children with asthma in outpatient settings.METHODS In total,100 pediatric patients with severe asthma were enrolled from January 2021 to November 2022 and randomly allocated to a control group(n=50)or an observation group(n=50).The control group received standard nursing care,including basic nursing interventions and health education upon admission.In contrast,the observation group was exposed to a broad spectrum of health education methodologies,including internet-based hospital systems,social media channels,one-on-one verbal education,informational brochures,slide present ations,telephone check-ins,animated videos,and illustrated health education manuals.Data on asthma management knowledge,symptom control,quality of life[St.George’s Respiratory Questionnaire(SGRQ)],treatment adherence,and nursing satisfaction were collected and analyzed.RESULTS The scores of the observation group in knowledge areas,such as medication,home care,disease understanding,symptom management,prevention strategies,and nutritional guidance,were significantly higher than those of the control group(P<0.05).In addition,the observation group exhibited greater symptom control,improved quality of life based on their SGRQ scores,and higher treatment adherence post-intervention(P<0.05).Nursing satisfaction was also rated higher in the observation group across all evaluated areas(P<0.05).CONCLUSION Implementing a diversified health education approach in pediatric asthma management significantly enhances disease understanding,symptom management,and treatment adherence,leading to improved quality of life for affected children.These findings underscore the importance of multifaceted clinical health education in augmenting disease awareness and facilitating continuous improvements in asthma control rates,highlighting the potential benefits of incorporating comprehensive educational strategies into pediatric asthma care protocols.
基金supported by the Fundamental Research Funds for the Central Universities(226-2022-00125)National Natural Science Foundation of China(U22A20383)Natural Science Foundation of Zhejiang Province(LD22H300002).
文摘Asthma is a widespread public health concern,with an increasing incidence.Despite the implementation of current treatment strategies,asthma control,particularly for severe cases,remains suboptimal.Recent research has revealed the encouraging prospects of extracellular vesicles(EVs)secreted by mesenchymal stem cells(MSCs)as a viable therapeutic option for alleviating asthma symptoms.Therefore,the present review aims to provide an overview of the current progress and the therapeutic mechanisms of using MSC-derived EVs(MSC-EVs)for asthma treatment.Additionally,different administration approaches for EVs and their impacts on biodistribution and the curative outcomes of EVs are summarized.Notably,the potential benefits of nebulized inhalation of MSC-EVs are addressed.Also,the possibilities and challenges of using MSC-EVs for asthma treatment in clinics are highlighted.Overall,this reviewis intended to give newinsight into the utilization of MSC-EVs as a potential biological drug for asthma treatment.
